Steris (FRA:2TG) Short Interest


FRA:2TG Steris PLC FRA:2TG
90 GF Score
Price €183.80
GF Value €238.39
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Steris Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:2TG vs ZBH, GEHC, DXCM: Short Interest Comparison

For the Medical Devices subindustry, Steris's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steris Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Steris's Short Interest distribution charts can be found below:

* The bar in red indicates where Steris's Short Interest falls into.


FRA:2TG
90GF Score
Steris PLC FRA:2TG
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Steris (FRA:2TG) Overvalued in 2026?

Based on GuruFocus' analysis, Steris stock appears to be undervalued. The current stock price of €183.80 is trading 22.9% below its estimated GF Value™ of €238.39. GuruFocus considers Steris to be Modestly Undervalued.

Key valuation signals for FRA:2TG:

  • Short Interest:
  • GF Value™: €238.39 vs. price of €183.80 (22.9% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the FRA:2TG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Steris Business Description

Other Exchanges STE:USAS1TE34:Brazil
Address 70 Sir John Rogerson\'s Quay, Dublin, IRL, D02 R296
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
90GF Score

Get the complete analysis for FRA:2TG

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€183.80
Price
€238.39
GF Value